LynkDose LynkDose
Cognitive & Nootropic Neurotrophic peptide derivative

P21

Also known as: P021 · Ciliary neurotrophic factor peptide

A small peptide derived from ciliary neurotrophic factor (CNTF) that is most associated in discussion with neurogenesis, BDNF signaling, and memory support.

Class

Neurotrophic peptide derivative

Default unit

mg

Common route

Subcutaneous

Typical half-life

Not well established

Frequency

Varies by use

Commonly associated areas

Illustrative map of the body systems P21 is most often discussed in relation to. Relative emphasis only — not a measure of efficacy or a medical claim.

Memory & learning 86
Neurogenesis 80
BDNF signaling 72
Neuroprotection 58
Mood support 44

Proposed mechanisms / pathways

BDNF / TrkB signaling Hippocampal neurogenesis CNTF-derived neurotrophic activity

What is P21?

P21 (also written P021) is a small peptide derivative of ciliary neurotrophic factor (CNTF), designed in research settings as a more drug-like fragment that retains some of the parent protein’s neurotrophic activity. It is discussed almost entirely in the context of neuroscience research — particularly neurogenesis, memory, and synaptic plasticity — rather than as an established supplement or medicine.

How it is thought to work

P21 is reported to promote neurogenesis (the formation of new neurons) and to enhance BDNF signaling, which is involved in learning and synaptic plasticity. Some research also describes effects on tau-related pathways in animal models. Because the evidence comes largely from laboratory and rodent studies rather than human trials, these mechanisms should be read as proposed and exploratory rather than confirmed.

Educational only — not medical advice

P21 is an early-stage research peptide that is not an approved medicine and has not been established for general human use, and nothing on this page is a recommendation, dose, or medical claim. Consult a qualified healthcare provider and follow the laws and regulations in your area.

Tracking P21 in LynkDose

Because P21 is a research-stage peptide with no well-defined dosing schedule or half-life, careful record-keeping is especially important. In LynkDose, log each dose with its date, amount, and reconstitution details, then add quick notes on memory, focus, and mood. Over time those structured entries turn isolated impressions into a trend you can review and discuss with a qualified professional.

Commonly discussed for

  • Memory and learning support
  • Neurogenesis and synaptic plasticity
  • General neuroprotection interest

Often stacked: Sometimes discussed alongside other research-stage neurotrophic or nootropic compounds, though stacking practices are not standardized and vary widely.

How to track P21 in LynkDose

P21 is an early-stage research peptide with no established cadence, so log every dose with its date and reconstitution details, then add short notes on memory, focus, and mood to watch for any subjective pattern over time.

Deeper read: How to Track a Peptide Cycle: A Complete Guide

Not medical advice

This page is educational and does not recommend, prescribe, or dose any compound. Many peptides are research chemicals not approved for general human use. Always consult a qualified healthcare provider and follow the laws in your area.

Related peptides